 Braxia Scientific Corp. CSE:BRAX, OTC:BRAXF has announced the appointments of Jason Wolkove as the companys new chief information officer CIO as well as Daniel Herrera as its new vice president of research development RD and growth. The medical research company said both roles will be integral to executing the expansion of Braxias clinical footprint, the rollout and expansion of novel ketamine and psilocybin therapy offerings, new special access programs, current and upcoming clinical trials, and the potential commercialization of future product development. 